|
⚲
|
| Keyboard |
| WuXi PharmaTech Healthcare Fund I LP
✚
|
|
|---|---|
| CIK # | 0001678057 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001678057] | |
| 4 | [0001678057] | |
| SC 13G | [0001678057] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| WuXi Pharmatech Healthcare Fund I LP | Ambrx Biopharma Inc | [2022-02-08] |
| WuXi Pharmatech Healthcare Fund I LP | Adagene Inc | [2022-01-26] |
| WuXi Pharmatech Healthcare Fund I LP | Unity Biotechnology Inc | [2021-01-08] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| WuXi AppTec Hong Kong Holding Ltd | |
| WuXi AppTec Co Ltd | |
| Ambrx Biopharma Cayman Inc | |
| WuXi PharmaTech Healthcare Fund I LP | |
| Syros Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2016-07-06 | Conversion | 531,858 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2016-07-06 | Conversion | 133,333 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2016-07-06 | Conversion | 133,333 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2016-07-06 | Conversion | 133,333 | ||
|
Syros Pharmaceuticals Inc SYRS
Series A-1 Preferred Stock · derivative
|
2016-07-06 | Conversion | 500,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Series B Preferred Stock · derivative
|
2016-07-06 | Conversion | 1,994,471 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Series A-3 Preferred Stock · derivative
|
2016-07-06 | Conversion | 500,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Series A-2 Preferred Stock · derivative
|
2016-07-06 | Conversion | 500,000 | $0.00 |